Stockreport

Analysts Are Betting On Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) With A Big Upgrade This Week [Yahoo! Finance]

Arcutis Biotherapeutics, Inc. - Common stock  (ARQT) 
PDF The revenue forecast for this year has experienced a facelift, with the analysts now much more optimistic on its sales pipeline. Following the upgrade, the current con [Read more]